Wednesday, November 22, 2023 10:54:26 AM
a total jumble of directions with phrases like ..."and thats not all!"... like some cheap product jinsu knives deal.
Further they close with an odd repetition of shares reduction...without context, as if an investor would not know that the 'reduction' came after a MUCH larger increase dilutuon several months earlier.
They need a competent editor.
Further, while products seem interesting there is no case made why these are better than like kind products in the market.
Seems to repeat the main RC liability... he doesnt know how to sell... only produce products. Like with KG they need a real CEO, real mass market sales sales leader... and make RC the product manager.
Still have a post on website for a VP of marketing...
Recent CAFI News
- Revolutionizing Wellness: Consumer Automotive Finance, Inc. Unveils Groundbreaking Mushroom Immune Booster and More in Exciting Supplement Expansion • InvestorsHub NewsWire • 11/14/2023 02:00:00 PM
- Consumer Automotive Finance, Inc. Announces Cancellation of 70,000,000 Common Shares • InvestorsHub NewsWire • 10/31/2023 01:00:00 PM
- Consumer Automotive Finance, Inc. Announces the Expansion of its Corporate Office to 11,000 Sq Ft to Accommodate Growth from its Subsidiaries • InvestorsHub NewsWire • 10/24/2023 01:00:00 PM
- Consumer Automotive Finance, Inc. Announces the Launch of its New Line of Sports Nutrition Products under its 51 Brand • InvestorsHub NewsWire • 10/11/2023 01:00:00 PM
- Consumer Automotive Finance, Inc. Announces New State-of-the-Art Corporate Headquarters, Accelerating Expansion into Sports and Nutrition Industry • InvestorsHub NewsWire • 08/22/2023 01:00:00 PM
- Consumer Automotive Finance, Inc. Announces Wholly Owned Subsidiary, 51, LLC Adds 10 Additional Products to Upcoming Launch • InvestorsHub NewsWire • 07/25/2023 01:00:00 PM
- Consumer Automotive Finance, Inc. Appoints Experienced CEO in Consumer Packaged Goods to Build Company into a Sports and Nutrition Powerhouse • InvestorsHub NewsWire • 07/12/2023 01:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM